Inventor · disambiguated record
Michael Siu
Also filed as: SIU MICHAEL · SIU MICHAEL K W
26 granted patents·24 pending applications·66 citations·filing 2004–2024
94Inventor score
Top patents by PatentIndex Score
50 records- 0190US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 0289US9266862B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2014·Granted Feb 23, 2016·9 cites·55 claims
- 0388US7928248B2Benzopyran and benzoxepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2009·Granted Apr 19, 2011·10 cites·14 claims
- 0487US10028954B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2016·Granted Jul 24, 2018·4 cites·60 claims
- 0587US8999998B2Pyrazolopyrimidine JAK inhibitor compounds and methodsGIBBONS PAUL·Filed 2010·Granted Apr 7, 2015·7 cites·1 claims
- 0685US8399690B24,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulene compoundsDO STEVEN·Filed 2011·Granted Mar 19, 2013·8 cites·9 claims
- 0785US2024150364A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2023·Application pending·0 cites
- 0882US8609687B2Triazolopyridine JAK inhibitor compounds and methodsZHU BING-YAN·Filed 2012·Granted Dec 17, 2013·7 cites·45 claims
- 0981US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 1080US11612606B28-aminoisoquinoline compounds and uses thereofGENENTECH INC·Filed 2019·Granted Mar 28, 2023·2 cites·29 claims
- 1180US10010549B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2015·Granted Jul 3, 2018·2 cites·10 claims
- 1280US9365583B2Substituted pyrazoles and uses thereofGENENTECH INC·Filed 2014·Granted Jun 14, 2016·3 cites·40 claims
- 1379US12338256B2Aza-tetracyclic oxazepine compounds and uses thereofGENENTECH INC·Filed 2024·Granted Jun 24, 2025·0 cites·28 claims
- 1479US8846762B2Benzopyran and benzoxepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2013·Granted Sep 30, 2014·3 cites·13 claims
- 1578USRE47848EBiheteroaryl compounds and uses thereofGENENTECH INC·Filed 2018·Granted Feb 11, 2020·1 cites·56 claims
- 1677US2022389020A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1777US2020171029A1Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 1875US2024368170A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 1973US11129832B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2019·Granted Sep 28, 2021·0 cites·27 claims
- 2072US9399636B2Substituted dipyridylamines and uses thereofGENENTECH INC·Filed 2014·Granted Jul 26, 2016·2 cites·17 claims
- 2172US2024025919A1Aza-tetracyclic oxazepine compounds and uses thereofGENENTECH INC·Filed 2023·Application pending·0 cites
- 2272US2025042919A1Tetracyclic oxazepine compounds and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 2371US10028942B23-substituted pyrazoles and uses thereofGENENTECH INC·Filed 2016·Granted Jul 24, 2018·1 cites·69 claims
- 2471US2020002345A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2019·Application pending·0 cites
- 2569US9434732B2Triazolopyridine JAK inhibitor compounds and methodsGENENTECH INC·Filed 2013·Granted Sep 6, 2016·1 cites·46 claims
- 2668US2024391930A1Spirocyclic bicyclic modulators of cholesterol biosynthesis and their use for promoting remyelinationGENENTECH INC·Filed 2024·Application pending·0 cites
- 2765US2018117044A1Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 2864US2018133219A1Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 2964US2017283424A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2017·Application pending·0 cites
- 3062US2022073520A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 3162US2010048557A1Triazolopyridine JAK Inhibitor Compounds and MethodsZHU BING-YAN·Filed 2009·Application pending·0 cites
- 3262US2010035875A1Triazolopyridine jak inhibitor compounds and methodsZHU BING-YAN·Filed 2009·Application pending·0 cites
- 3362US2022281893A1Tetracyclic oxazepine compounds and uses thereofGENENTECH INC·Filed 2022·Application pending·0 cites
- 3461US9309265B2Benzopyran and benzoxepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2014·Granted Apr 12, 2016·0 cites·12 claims
- 3558US2014378449A1Triazolopyridine jak inhibitor compounds and methodsGENENTECH INC·Filed 2014·Application pending·0 cites
- 3656US8889673B2Triazolopyridine JAK inhibitor compounds and methodsZHU BING-YAN·Filed 2012·Granted Nov 18, 2014·0 cites·6 claims
- 3754US2015152117A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2015·Application pending·0 cites
- 3853US12473301B2Isoquinoline compounds for the treatment of cancerGENENTECH INC·Filed 2021·Granted Nov 18, 2025·0 cites·18 claims
- 3953US12378249B2Isoquinoline compounds and uses thereofGENENTECH INC·Filed 2021·Granted Aug 5, 2025·0 cites·25 claims
- 4053US12297210B2Naphthyridine compounds and uses thereofGENENTECH INC·Filed 2021·Granted May 13, 2025·0 cites·15 claims
- 4153US2024383915A1Oxazepine compounds and uses thereof in the treatment of cancerGENENTECH INC·Filed 2022·Application pending·0 cites
- 4252US2016333011A1Triazolopyridine jak inhibitor compounds and methodsGENENTECH INC·Filed 2016·Application pending·0 cites
- 4349US2008226554A1Methods For Detecting Markers Associated With Endometrial Disease or PhaseMOUNT SINAI HOSPITAL CORP·Filed 2004·Application pending·0 cites
- 4448US2016024089A1Triazolopyridine jak inhibitor compounds and methodsGENENTECH INC·Filed 2015·Application pending·0 cites
- 4546US7462634B2N-(pyridin-2-yl)-sulfonamide derivativesAGOURON PHARMA·Filed 2006·Granted Dec 9, 2008·0 cites·11 claims
- 4645US2005148631A1Amino heterocyclyl inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1AGOURON PHARMA·Filed 2004·Application pending·0 cites
- 4742US9550777B23-substituted pyrazoles and use as DLK inhibitorsGENENTECH INC·Filed 2015·Granted Jan 24, 2017·0 cites·30 claims
- 4841US10131675B2Tricyclic DLK inhibitors and uses thereofGENENTECH INC·Filed 2017·Granted Nov 20, 2018·0 cites·34 claims
- 4939US2012065195A1Compounds for treating neurodegenerative diseasesCLARK CHRISTOPHER T·Filed 2011·Application pending·0 cites
- 5035US2012157448A1Compounds for treating neurodegenerative diseasesCOOK ADAM·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Siu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →